Inhibition of Tumor Growth and Invasion by a Four-Kringle Antagonist (HGF/NK4) for Hepatocyte Growth Factor
The result: a widening gap between ROS generation and antioxidant capacity that manifests as fatigue, cognitive dysfunction, and delayed recovery from exercise
People with active cancer should consult their healthcare provider before using GHK-Cu because the peptide promotes angiogenesis, which could theoretically supply blood to tumors
A: It can be used with other medications, but it should not be used with other GLP-1 medications
A major source of hepatic fat is fat mobilization from adipose tissue
GHK-Cu appears in research contexts involving copper peptide research, extracellular matrix models, topical formulation studies, skin and hair follicle research